IP Library Granted Patent US 10,590,171
Granted Patent B2
US 10,590,171 · App. 15/795,729 · Granted Mar 17, 2020

Exosomes and methods of making and using the same

Inventors: Jesus A. Silvas (Fayetteville, GA); Patricia V. Aguilar (Galveston, TX); Vsevolod L. Popov (Galveston, TX)
Assignee: The Board of Regents of the University of Texas System
C07K14/005A61K47/42C07K14/70596C12N7/00C12N2740/16043C12N2760/12221C12N2760/12222
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,590,171
App. No.
15/795,729
Granted
Mar 17, 2020
Kind
B2
Abstract

Provided herein are isolated exosomes. An exome can include a nonstructural (NSs) protein of a virus, a glycoprotein (Gn protein) of a virus, or a combination thereof. The virus is a member of the Order Bunyavirales, such as a member of the genus Phlebovirus . In one embodiment, the virus is Severe Fever with Thrombocytopenia Syndrome (SFTS) virus. Also provided are methods for making and using the exosomes described herein.

Claims (14)

1. A method for making an exosome comprising

incubating an engineered cell under conditions suitable for production of an extracellular exosome, wherein the engineered cell comprises an exogenous polynucleotide encoding a nonstructural (NSs) protein of a virus that is a member of the Order Bunyavirales, or an active fragment thereof, wherein the extracellular exosome comprises marker LC3.

2. The method of claim 1 further comprising isolating the extracellular exosome.

3. The method of claim 1 wherein the virus is a member of the genus Phlebovirus.

4. The method of claim 3 wherein the member of the genus Phlebovirus is Severe fever with thrombocytopenia syndrome (SFTS) virus.

5. The method of claim 1 wherein the NSs protein has at least 80% similarity with SEQ ID NO:1.

6. The method of claim 1 wherein the number of extracellular exosomes produced by the cell is increased by at least 10-fold compared to the same cell that does not comprise the exogenous polynucleotide.

7. The method of claim 1 further comprising a glycoprotein (Gn protein) of a virus that is a member of the Order Bunyavirales, or an active fragment thereof.

8. The method of claim 1 wherein the extracellular exosome does not comprise a Severe fever with thrombocytopenia syndrome (SFTS) virus.

9. The method of claim 1 wherein the extracellular exosome further comprises an agent.

10. The method of claim 1 wherein the agent comprises a polynucleotide.

11. The method of claim 10 wherein the polynucleotide comprises mRNA, tRNA, rRNA, siRNA, microRNA, non-coding RNA, coding RNA, or DNA.

12. The method of claim 7 wherein the Gn protein has at least 80% similarity with SEQ ID NO:2.

13. The method of claim 7 wherein the Gn protein comprises SEQ ID NO:2.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 16, 2018
From: UNIVERSITY OF TEXAS MED BR GALVESTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046548/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2018
From: SILVAS, JESUS A.; AGUILAR, PATRICIA V.; POPOV, VSEVOLOD L.
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 045670/0236 →
Continuity (2)
Provisional Application 62414416 · Oct 28, 2016
Related Publication 20180134754A1 · May 17, 2018
Cited By (1)
US 12,268,785